Development and validation of a monoclonal antibody-based solid-phase competitive ELISA for post-vaccination seromonitoring of foot-and-mouth disease virus serotype O
This study developed and validated a highly sensitive, specific, and reproducible monoclonal antibody-based solid-phase competitive ELISA that offers a standardized and sustainable alternative to conventional hyperimmune serum-dependent assays for large-scale post-vaccination seromonitoring of foot-and-mouth disease virus serotype O in cattle and buffalo.